What is the appropriate dosing, monitoring, contraindications, and adverse effects of fludrocortisone acetate 0.1 mg oral tablet for primary adrenal insufficiency and orthostatic hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fludrocortisone Acetate 0.1 mg Oral Tablet: Dosing, Monitoring, and Management

Standard Dosing

Most patients with primary adrenal insufficiency should take 50–200 µg (0.05–0.2 mg) fludrocortisone as a single daily dose taken upon awakening, with 100 µg (0.1 mg) daily being the most common starting dose. 1, 2

Dosing by Population:

  • Adults with PAI: 50–200 µg daily, typically starting at 100 µg 1, 2
  • Children and younger adults: Often require higher doses, up to 500 µg daily due to physiological differences 1, 3
  • Pregnancy (third trimester): May require up to 500 µg daily due to progesterone's anti-mineralocorticoid effects 1
  • Salt-losing congenital adrenal hyperplasia: 100–200 µg daily 2

Critical Administration Details:

  • Take as a single morning dose upon awakening—never use alternate-day dosing 1, 3
  • Tablets may be kept at room temperature despite package labeling requiring refrigeration (decay rate only 0.1% in 6 months at room temperature) 1
  • Must be taken daily without interruption to prevent dangerous electrolyte fluctuations and adrenal crisis 3

Monitoring Parameters

Clinical Assessment (at every visit):

  • Blood pressure in both supine AND standing positions: Orthostatic hypotension indicates under-replacement; hypertension indicates over-replacement 1, 4, 3
  • Salt craving or lightheadedness: Suggests under-replacement 1, 4
  • Peripheral edema: Suggests over-replacement 1, 4
  • Weight monitoring: Assess for fluid retention 1

Laboratory Monitoring:

  • Serum sodium and potassium: Low sodium or high potassium warrant dose increases by 0.05 mg increments 4, 2, 5
  • Plasma renin activity (PRA): Target the upper half of normal range; low-normal PRA suggests over-replacement, elevated PRA suggests under-replacement 4, 5, 6
  • Monitor at baseline, then at least annually 1, 4

Follow-up Schedule:

  • Annual minimum review with assessment of health, well-being, weight, blood pressure, and serum electrolytes 1, 4
  • Screen periodically for new autoimmune disorders (particularly hypothyroidism) 1
  • Bone mineral density every 3–5 years to assess for glucocorticoid-related complications 1

Contraindications and Drug Interactions

Absolute Contraindications:

  • Systemic fungal infections (general corticosteroid contraindication) 2

Medications to AVOID (interact dangerously with fludrocortisone):

  • Diuretics (all types, including thiazides, loop diuretics) 1, 4, 3
  • Acetazolamide 1, 4
  • NSAIDs 1, 4, 3
  • Carbenoxolone and licorice (potentiate mineralocorticoid effects, causing hypertension) 1, 4, 3
  • Grapefruit juice (potentiates mineralocorticoid effects) 1, 4, 3

Medications Requiring Dose Adjustment:

  • Drospirenone-containing contraceptives: May require increased fludrocortisone dose 1
  • Digitalis glycosides: Enhanced risk of arrhythmias due to hypokalemia; monitor potassium closely 2
  • Potassium-depleting diuretics and amphotericin B: Enhanced hypokalemia risk; check potassium frequently 2
  • Oral anticoagulants: Decreased prothrombin time response 2

Use with Caution:

  • Hypothyroidism or cirrhosis: Enhanced corticosteroid effects 2
  • Ocular herpes simplex: Risk of corneal perforation 2
  • Nonspecific ulcerative colitis, diverticulitis, peptic ulcer disease: Risk of perforation 2
  • Renal insufficiency, hypertension, osteoporosis, myasthenia gravis: Requires careful monitoring 2

Adverse Effects and Management

Common Adverse Effects:

  • Hypertension: Reduce dose by 0.05 mg but never discontinue completely (risk of adrenal crisis) 1, 4, 3
  • Peripheral edema: Indicates over-replacement; reduce dose 1, 4
  • Hypokalemia: Enhanced with concurrent potassium-depleting drugs; supplement potassium if needed 2
  • Hypernatremia: Monitor electrolytes regularly 7

Serious Adverse Effects:

  • Congestive heart failure: Especially with chronic use or over-replacement 7
  • Hyperglycemia: Monitor in diabetic patients 7
  • Arrhythmias: Particularly with concurrent digitalis use and hypokalemia 2
  • Psychic derangements: Range from euphoria to severe depression or psychosis 2

Signs of Under-Replacement (Common Pitfall):

  • Under-replacement is more common than over-replacement and predisposes to recurrent adrenal crises 1, 3
  • Persistent salt craving, orthostatic hypotension, lightheadedness, elevated PRA, hyponatremia, hyperkalemia 1, 4, 5
  • Do not compensate for mineralocorticoid under-replacement by increasing glucocorticoid doses 1

Special Situations and Dose Adjustments

Pregnancy:

  • Small dose adjustments may be needed, particularly in the third trimester (up to 500 µg daily) due to progesterone's anti-mineralocorticoid activity 1
  • Parenteral hydrocortisone required during delivery 1

Surgery and Invasive Procedures:

  • Continue fludrocortisone at usual dose 1
  • Increase glucocorticoid (hydrocortisone) coverage as needed 1

Hypertension Management:

  • If essential hypertension develops, reduce fludrocortisone dose but never stop completely 1
  • Add vasodilator therapy if needed rather than discontinuing mineralocorticoid 1
  • Monitor for hyperkalemia with dose reduction 4

High Ambient Temperature:

  • May require dose adjustments to avoid sodium depletion 6

Patient Education Essentials

Critical Safety Information:

  • Wear medical alert identification jewelry and carry a steroid alert card at all times 1
  • Carry emergency injectable hydrocortisone (100 mg IM) and know how to self-administer 1, 4
  • Never skip doses or attempt alternate-day dosing (risk of adrenal crisis) 3

Dietary Recommendations:

  • Consume salt and salty foods ad libitum (without restriction) 1, 3
  • Avoid potassium-containing salt substitutes (often marketed as "healthy salts") 1, 3
  • Avoid licorice and grapefruit juice completely 1, 4, 3

Stress Dose Protocols:

  • Double or triple hydrocortisone dose during febrile illness, gastroenteritis, or significant physical stress 4
  • Use emergency injectable hydrocortisone (100 mg IM) if unable to take oral medications or during severe illness 4
  • Seek immediate medical attention for signs of adrenal crisis 1

Missed Dose Instructions:

  • Take as soon as remembered unless almost time for next dose 2
  • Never double the next dose 2

Algorithm for Dose Titration

Starting dose: 100 µg (0.1 mg) daily upon awakening 2

If Under-Replacement Signs Present (salt craving, orthostatic hypotension, elevated PRA, hyponatremia, hyperkalemia):

  1. Increase by 50 µg (0.05 mg) increments 4, 2
  2. Reassess in 2–4 weeks with blood pressure (supine/standing), electrolytes, and PRA 4
  3. Continue titrating until symptoms resolve and PRA in upper normal range 4, 6

If Over-Replacement Signs Present (hypertension, edema, suppressed PRA):

  1. Decrease by 50 µg (0.05 mg) but never discontinue completely 1, 4, 2
  2. Monitor for rebound hyperkalemia 4
  3. Consider adding vasodilator if hypertension persists despite dose reduction 1

Long-Term Follow-Up:

  • Fludrocortisone dose may be reduced over time (>60 months follow-up) as patients stabilize 5
  • Continue annual monitoring indefinitely 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Daily Fludrocortisone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Optimizing Cardiovascular Health in Primary Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

Best practice & research. Clinical endocrinology & metabolism, 2015

Research

[Synthetic mineralocorticoid].

Nihon rinsho. Japanese journal of clinical medicine, 2008

Related Questions

Can a decreased mineralocorticoid (corticosteroid that regulates electrolyte and water balance) dosage in primary adrenal insufficiency cause impaired renal function (decreased estimated Glomerular Filtration Rate, eGFR)?
Is 0.15mg of mineralocorticoid (e.g. fludrocortisone) too high a dose?
What symptoms should be monitored when decreasing the dose of fludrocortisone (mineralocorticoid)?
In a patient with primary adrenal insufficiency, will increasing mineralocorticoids (e.g. fludrocortisone) or glucocorticoids (e.g. hydrocortisone) have a more significant impact on improving mineral balance?
What is the recommended mineralocorticoid replacement regimen for primary adrenal insufficiency?
What are the ICD‑10‑CM codes for current tobacco use, nicotine dependence, current cannabis use, cannabis dependence, and past cannabis use?
In a 35-year-old woman with green‑yellow purulent vaginal discharge that began after menstruation, multifocal rounded erythematous macules on the vaginal mucosa, and pelvic tenderness, which is the most likely diagnosis: vaginal candidiasis, bacterial vaginosis, atrophic vaginitis, or vaginal trichomoniasis?
Why was the fasting glucose reference range (60‑100 mg/dL) applied to my 100 mg/dL result instead of the non‑fasting reference range (up to 140 mg/dL)?
What is the recommended comprehensive eye examination and differential diagnosis for a patient presenting with ocular symptoms?
What are the likely causes and appropriate acute and preventive treatments for occipital headaches that occur with menses in a reproductive‑age woman?
What creatine kinase level defines rhabdomyolysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.